Lennard, Lynne
26  results:
Search for persons X
?
 
?
3

Implementation of TPMT testing:

Lennard, Lynne
British Journal of Clinical Pharmacology.  77 (2014)  4 - p. 704-714 , 2014
 
?
 
?
 
?
6

Thiopurine methyltransferase genotype-phenotype discordance..:

Lennard, Lynne ; Cartwright, Cher Suzanne ; Wade, Rachel..
British Journal of Clinical Pharmacology.  76 (2013)  1 - p. 125-136 , 2013
 
?
8

Response to Piel et al:

Stoneham, Sara ; Lennard, Lynne ; Coen, Pietro..
British Journal of Haematology.  125 (2004)  3 - p. 412-412 , 2004
 
?
 
?
10

Veno‐occlusive disease in patients receiving thiopurines du..:

Stoneham, Sara ; Lennard, Lynne ; Coen, Pietro..
British Journal of Haematology.  123 (2003)  1 - p. 100-102 , 2003
 
?
11

Clinical Implications of Thiopurine Methyltransferase-Optim..:

Lennard, Lynne
Therapeutic Drug Monitoring.  20 (1998)  5 - p. 527-531 , 1998
 
?
13

Olsalazine and 6-mercaptopurine-related bone marrow suppres..:

Lewis, Lionel D. ; Benin, Andrea ; Szumlanski, Carol L....
Clinical Pharmacology & Therapeutics.  62 (1997)  4 - p. 464-475 , 1997
 
?
14

Human thiopurine methyltransferase pharmacogenetics: Gene s..:

Otterness, Diane ; Szumlanski, Carol ; Lennard, Lynne...
Clinical Pharmacology & Therapeutics.  62 (1997)  1 - p. 60-73 , 1997
 
?
 
1-15